Malignant melanoma with areas of rhabdomyosarcomatous differentiation arising in a giant congenital nevus with RAF1 gene fusion.


Journal

Pigment cell & melanoma research
ISSN: 1755-148X
Titre abrégé: Pigment Cell Melanoma Res
Pays: England
ID NLM: 101318927

Informations de publication

Date de publication:
09 2019
Historique:
received: 19 10 2018
revised: 10 03 2019
accepted: 23 03 2019
pubmed: 5 4 2019
medline: 26 3 2020
entrez: 5 4 2019
Statut: ppublish

Résumé

A girl, born with a posterior  lumbosacral giant congenital nevus, developed a central nodule that expanded over a period of 14 months into a 10-cm pedunculated mass. Histological analysis of the mass revealed melanoma of myxoid, small round-cell type with areas of  rhabdomyosarcomatous  transformation confirmed by immunohistochemistry. RNA sequencing identified an in-frame SASS6(e14)-RAF1(e8) fusion in both components and the nevus. A RAF1 FISH break-apart test found a balanced rearrangement pattern in the nevus and an unbalanced pattern in the malignant areas. Wild-type status of NRAS and BRAF was confirmed by NGS techniques. The array-CGH profile displayed copy number alterations commonly found in rhabdomyosarcomas. Despite intensive treatment, widespread metastatic evolution of the melanomatous component was observed.

Identifiants

pubmed: 30945443
doi: 10.1111/pcmr.12785
doi:

Substances chimiques

Proto-Oncogene Proteins c-raf EC 2.7.11.1
Raf1 protein, human EC 2.7.11.1

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

708-713

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Bahrami, A., Lee, S., Wu, G., Kerstetter, J., Rahvar, M., Li, X., … Barnhill, R. L. (2016). Pigment-synthesizing melanocytic neoplasm with protein kinase C alpha (PRKCA) fusion. JAMA Dermatology, 152(3), 318. https://doi.org/10.1001/jamadermatol.2015.2524
Bauer, J., & Bastian, B. C. (2006). Distinguishing melanocytic nevi from melanoma by DNA copy number changes: Comparative genomic hybridization as a research and diagnostic tool. Dermatologic Therapy, 19(1), 40-49. https://doi.org/10.1111/j.1529-8019.2005.00055.x
Bridge, J. A., Liu, J., Qualman, S. J., Suijkerbuijk, R., Wenger, G., Zhang, J. I., … Barr, F. G. (2002). Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes, Chromosomes and Cancer, 33(3), 310-321. https://doi.org/10.1002/gcc.10026 https://doi.org/10.1002/gcc.10026
Busam, K. J., Shah, K. N., Gerami, P., Sitzman, T., Jungbluth, A. A., & Kinsler, V. (2017). Reduced H3K27me3 expression is common in nodular melanomas of childhood associated with congenital melanocytic nevi but not in proliferative nodules. The American Journal of Surgical Pathology, 41(3), 396-404. https://doi.org/10.1097/PAS.0000000000000769
Christman, M. P., Kerner, J. K., Cheng, C., Piris, A., Nepo, A. G., Sepehr, A., & Kroshinsky, D. (2014). Rhabdomyosarcoma arising in a giant congenital melanocytic nevus. Pediatric Dermatology, 31(5), 584-587. https://doi.org/10.1111/pde.12359
Dessars, B., De Raeve, L. E., Housni, H. E., Debouck, C. J., Sidon, P. J., Morandini, R., … Heimann, P. (2007). Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi. Journal of Investigative Dermatology, 127(6), 1468-1470. https://doi.org/10.1038/sj.jid.5700725
Elder, D., Massi, D., Scolyer, R., & Willemze, R. (2018). WHO classification of skin tumours (Vol. 11, 4th ed.). Lyon, France: World Health Organization.
Etchevers, H. C., Rose, C., Kahle, B., Vorbringer, H., Fina, F., Heux, P., … Krengel, S. (2018). Giant congenital melanocytic nevus with vascular malformation and epidermal cysts associated with a somatic activating mutation in BRAF. Pigment Cell and Melanoma Research, 31(3), 437-441. https://doi.org/10.1111/pcmr.12685
Gordon, T., McManus, A., Anderson, J., Min, T., Swansbury, J., Pritchard-Jones, K. … United Kingdom Cancer Cytogenetics Group (2001). Cytogenetic abnormalities in 42 rhabdomyosarcoma: A United Kingdom cancer cytogenetics group study. Medical and Pediatric Oncology, 36(2), 259-267. https://doi.org/10.1002/1096-911X(20010201)36:2<259:AID-MPO1063>3.0.CO;2-K
Kinsler, V. A., O'Hare, P., Bulstrode, N., Calonje, J. E., Chong, W. K., Hargrave, D., … Slater, O. (2017). Melanoma in congenital melanocytic naevi. The British Journal of Dermatology, 176(5), 1131-1143. https://doi.org/10.1111/bjd.15301
Kinsler, V. A., Thomas, A. C., Ishida, M., Bulstrode, N. W., Loughlin, S., Hing, S., … Moore, G. E. (2013). Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. The Journal of Investigative Dermatology, 133(9), 2229-2236. https://doi.org/10.1038/jid.2013.70
Koyama, T., Murakami, M., & Nishihara, O. (1996). Congenital melanoma: A case suggesting rhabdomyogenic differentiation. Pediatric Dermatology, 13(5), 389-393. https://doi.org/10.1111/j.1525-1470.1996.tb00707.x
Krengel, S., Scope, A., Dusza, S. W., Vonthein, R., & Marghoob, A. A. (2013). New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. Journal of the American Academy of Dermatology, 68(3), 441-451. https://doi.org/10.1016/j.jaad.2012.05.043
Leidel, S., Delattre, M., Cerutti, L., Baumer, K., & Gönczy, P. (2005). SAS-6 defines a protein family required for centrosome duplication in C. elegans and in human cells. Nature Cell Biology, 7(2), 115-125. https://doi.org/10.1038/ncb1220
Martins da Silva, V., Martinez-Barrios, E., Tell-Martí, G., Dabad, M., Carrera, C., Aguilera, P., … Malvehy, J. (2018). Genetic abnormalities in large to giant congenital nevi: Beyond NRAS mutations. The Journal of Investigative Dermatology, 139(4), 900-908. https://doi.org/10.1016/j.jid.2018.07.045
Nishimura, R., Takita, J., Sato-Otsubo, A., Kato, M., Koh, K., Hanada, R., … Ogawa, S. (2013). Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array. Cancer Science, 104(7), 856-864. https://doi.org/10.1111/cas.12173
Padilla, R. S., McConnell, T. S., Gribble, J. T., & Smoot, C. (1988). Malignant melanoma arising in a giant congenital melanocytic nevus. A case report with cytogenetic and histopathologic analyses. Cancer, 62(12), 2589-2594.
Palanisamy, N., Ateeq, B., Kalyana-Sundaram, S., Pflueger, D., Ramnarayanan, K., Shankar, S., … Chinnaiyan, A. M. (2010). Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nature Medicine, 16(7), 793-798. https://doi.org/10.1038/nm.2166
Papp, T., Schipper, H., Kumar, K., Schiffmann, D., & Zimmermann, R. (2005). Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi. Melanoma Research, 15(5), 401-407. https://doi.org/10.1097/00008390-200510000-00008 https://doi.org/10.1097/00008390-200510000-00008
Perron, E., Pissaloux, D., Charon Barra, C., Karanian, M., Lamant, L., Parfait, S., … de la Fouchardière, A. (2018). Melanocytic myxoid spindle cell tumor with ALK rearrangement (MMySTAR): Report of 4 cases of a nevus variant with potential diagnostic challenge. The American Journal of Surgical Pathology, 42(5) 595-603. https://doi.org/10.1097/PAS.0000000000000973
Richardson, S. K., Tannous, Z. S., & Mihm, M. C. (2002). Congenital and infantile melanoma: Review of the literature and report of an uncommon variant, pigment-synthesizing melanoma. Journal of the American Academy of Dermatology, 47(1), 77-90. https://doi.org/10.1067/mjd.2002.120602
Salgado, C. M., Basu, D., Nikiforova, M., Bauer, B. S., Johnson, D., Rundell, V., … Reyes-Múgica, M. (2015). BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi. Pediatric and Developmental Pathology, 18(1), 1-9. https://doi.org/10.2350/14-10-1566-OA.1
Stransky, N., Cerami, E., Schalm, S., Kim, J. L., & Lengauer, C. (2014). The landscape of kinase fusions in cancer. Nature Communications, 5(1), 484610.1038/ncomms5846
Su, A., Low, L., Li, X., Zhou, S., Mascarenhas, L., & Barnhill, R. L. (2014). De novo congenital melanoma: Analysis of 2 cases with array comparative genomic hybridization. The American Journal of Dermatopathology, 36(11), 915-919. https://doi.org/10.1097/DAD.0000000000000128
Tran, T. A. N., Linos, K., de Abreu, F. B., & Carlson, J. A. (2018). Undifferentiated sarcoma as intermediate step in the progression of malignant melanoma to rhabdomyosarcoma: Histologic, immunohistochemical, and molecular studies of a new case of malignant melanoma with rhabdomyosarcomatous differentiation. The American Journal of Dermatopathology, 41(3), 221-229. https://doi.org/10.1097/DAD.0000000000001236

Auteurs

Aline Baltres (A)

Department of Biopathology, Centre Léon Bérard, Lyon, France.

Aicha Salhi (A)

Department of Dermatology, Medical Clinic Les Orangers, University of Alger Medical School, Algiers, Algeria.

Aurelie Houlier (A)

Department of Biopathology, Centre Léon Bérard, Lyon, France.
CNRS 5286, INSERM U1052, Cancer Research Centre of Lyon, University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Daniel Pissaloux (D)

Department of Biopathology, Centre Léon Bérard, Lyon, France.
CNRS 5286, INSERM U1052, Cancer Research Centre of Lyon, University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Franck Tirode (F)

CNRS 5286, INSERM U1052, Cancer Research Centre of Lyon, University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Véronique Haddad (V)

Department of Biopathology, Centre Léon Bérard, Lyon, France.

Marie Karanian (M)

Department of Biopathology, Centre Léon Bérard, Lyon, France.
CNRS 5286, INSERM U1052, Cancer Research Centre of Lyon, University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Salim Ysmail-Dahlouk (S)

Department of Pathology, Central Hospital of Army, Algiers, Algeria.

Fatma Boukendakdji (F)

Pediatric Department, Central Hospital of Army, Algiers, Algeria.

Djazia Dahlouk (D)

Pediatric Department, Central Hospital of Army, Algiers, Algeria.

Fateh Allaoua (F)

Department of Plastic Surgery, Central Hospital of Army, Algiers, Algeria.

Marzak Metref (M)

Department of Plastic Surgery, Central Hospital of Army, Algiers, Algeria.

Assya Djeridane (A)

Department of Dermatology, Central Hospital of Army, Algiers, Algeria.

Sylvie Fraitag (S)

Department of Pathology, APHP, Hôpital Necker-Enfants Malades, Paris, France.

Arnaud de la Fouchardière (A)

Department of Biopathology, Centre Léon Bérard, Lyon, France.
CNRS 5286, INSERM U1052, Cancer Research Centre of Lyon, University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH